PD‐L1 was expressed in abundance (tumor proportion score ≥50%) in 51 (25%) patients, expressed at low levels (1% ≤ tumor proportion score <50%), absent (tumor proportion score <1%), and unknown in 152 (75%) patients. This evidence concerns the gene CD274 and neoplasm.